|
 |
The Medical Management of HIV/AIDS
The University of California, San Francisco School of Medicine
|
|
Order Today and Save 50%! The Medical Management of HIV/AIDS provides the active intermediate to advanced HIV clinician with a comprehensive review of the science and application of HIV therapy.
Lectures are presented by a group of leading clinicians and researchers who are also dedicated to teaching in their area of expertise. Topics include current dilemmas in antiretroviral therapy, post exposure prophylaxis, common metabolic and drug toxicities, as well as HIV/HCV/HBV co-infection.
| CREDITS |
N/A |
| CE RELEASE |
N/A |
| CE EXPIRE |
N/A |
|
|
|
 |
|
|
| Special pricing for clinic-wide orders or for group subscriptions/purchases. Minimum order quantities apply for eligible discounts. For further information and pricing estimates, contact Rebecca Sims at 800-633-4743 x3039. For all other sales inquiries, call 1-800-633-4743. |
 |
Intended Audience
The Medical Management of HIV/AIDS multimedia program is well designed for practicing HIV clinicians including internists, family practitioners, infectious disease specialists, nurse practitioners, and physician assistants.
Topics & Speakers
Top Ten Stories of HIV Medicine
2007
Diane V. Havlir, MD
Meg D. Newman, MD
Global Prevention
in 2007
Nancy Padlan, MD
Deciphering HIV
Pathogenesis
Warner Greene, MD, PhD
Antiretrovirals in
Development: New Drugs,
New Classes, New
Challenges
C. Bradley Hare, MD
HIV Drug Resistance
Update
Harry Lampiris, MD
What’s New in HIV
Dermatology
Toby Maurer, MD
Hepatitis B / HIV
Co-infection
Annie Luetkemeyer, MD
Dilemmas in HIV and
Hepatitis C Management
C. Bradley Hare, MD
Hepatitis
Co-Infection Panel
Annie Luetkemeyer, MD
C. Bradley Hare, MD
Metabolic
Complications in the HAART Era
Morris Schambelan, MD
International Track
Part 2
–– Malaria and HIV
Philip J. Rosenthal, MD
HIV-Associated
Pulmonary Disease:
Classic and
Challenging Cases
for the Clinician
Laurence Huang, MD
|
Cases in ARV Resistance
Jason Tokumoto, MD
Women and HIV: A
Case Based Approach
Monica Gandhi, MD, MPH
MRSA in Clinical
Care
Lisa G. Winston, MD
STD Management for
the HIV
Care Provider:
What’s New in the
CDC 2006 STD
Treatment Guidelines
Gail Bolan, MD
Acute HIV
Christopher Pilcher, MD
Post Exposure
Prophylaxis in 2007
Amy Kindrick, MD, MPH
Psychiatry and HIV
Dan Karasic, MD
Anal Dysplasia in
HIV Positive
Men and Women: An
Update
Joel M. Palefsky, MD
Update in HIV-Related Renal Disease
Andy Choi, MD
HIV Neurological
Disease
Cheryl Jay, MD
Methamphetamine and
Club Drugs
Grant Colfax, MD
|
FACULTY |
| Course
Directors |
Diane V. Havlir, MD
Professor of
Medicine
Chief, HIV/AIDS
Division
Director, Positive
Health Program
San Francisco
General Hospital
University of
California, San Francisco |
Meg
D. Newman, MD
Associate
Professor of Clinical Medicine
Director, PHP-HIV
Clinical Scholars Program
Positive Health
Program
San Francisco
General Hospital
University of
California, San Francisco
|
COURSE FACULTY
(University of
California, San Francisco,
School of Medicine
unless otherwise noted.) |
|
Gail Bolan, MD
Assistant Clinical
Professor of Medicine
Chief, STD Control
Branch
California
Department of Health Services,
Berkeley
Andy Choi, MD
Adjunct Instructor
of Nephrology
Grant Colfax, MD
Director of HIV
Prevention and
Research at SFDPH
Monica Gandhi, MD,
MPH
Assistant
Professor of Medicine
Division of Infectious Disease
Warner Greene, MD,
PhD
Director,
Gladstone Institute of
Virology and Immunology
Professor of
Medicine
Microbiology and Immunology
Co-Director,
UCSF-GIVI Center for
AIDS Research
C. Bradley Hare, MD
Assistant Clinical
Professor
Positive Health Program, SFGH
Laurence Huang, MD
Associate
Professor of Clinical Medicine
Chief, AIDS Chest
Clinic, SFGH
Cheryl Jay, MD
Clinical Professor of Neurology
Dan Karasic, MD
Associate Clinical Professor of Psychiatry
Attending Psychiatrist for AIDS Care, SFGH
Amy
Kindrick, MD, MPH
Senior Consultant,
National HIV/AIDS Clinicians’
Consultation
Center; Associate Physician,
Department of
Family and
Community Medicine |
Harry Lampiris, MD
Associate
Professor of Clinical Medicine
Infectious Disease
Section
Department of Medicine
San Francisco VA
Medical Center
Annie Luetkemeyer,
MD
Clinical Fellow
Positive Health Program, SFGH
Toby Maurer, MD
Associate
Professor of Dermatology
Joel M. Palefsky, MD
Professor of
Medicine
Division of Infectious Disease
Christopher D. Pilcher, MD
Associate Professor in Residence Attending Physician, Positive Health Practice, SFGH
Philip J.
Rosenthal, MD
Professor of
Medicine
Division of Infectious Disease
Morris Schambelan,
MD
Associate Chair
for Clinical and
Translational Research
Program Director,
CTSI Clinical
Research Center
Jason Tokumoto, MD
Assistant Clinical
Professor of Medicine
Lisa G. Winston
Assistant Clinical
Professor of Medicine
Division of
Infectious Disease, SFGH
|
Learning Objectives
At the conclusion of this Medical Management of HIV/AIDS multimedia program, participants will be able to discuss:
- Recent changes in the epidemiology of AIDS nationally and globally
- New developments in the understanding of HIV pathogenesis
- Antiretroviral resistance and current strategies for salvage therapy
- Current recommendations for the management of occupational and sexual post exposure
prophylaxis (PEP), HCV and/or HBV co-infection with HIV
- New developments in HIV-related dermatologic, pulmonary, HIV
transplant, HIV-Related renal,
neurological, and psychiatric disease
Accreditation Statement
The University of California, San Francisco School of Medicine (UCSF) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Faculty Disclosure
Faculty for UCSF’s Continuing Medical Education Program must complete a Declaration of Disclosure prior to the CME activity. Having an interest in or affiliation with a commercial entity does not preclude making a presentation at a CME activity, but the relationship must be disclosed in advance and any potential conflict of interest must be resolved in accordance with the ACCME Updated Standards for Commercial Support. Disclosure must be conveyed to the learning audience prior to the educational offering; presentation of information on investigational/off-label use of pharmaceuticals or medical devices must also be disclosed. Full disclosure of faculty is listed in the syllabus.
|
 |
| |
|
 |
|
|